Isorhapontigenin ameliorates high glucose-induced podocyte and vascular endothelial cell injuries via mitigating oxidative stress and autophagy through the AMPK/Nrf2 pathway
- PMID: 35960477
- DOI: 10.1007/s11255-022-03325-y
Isorhapontigenin ameliorates high glucose-induced podocyte and vascular endothelial cell injuries via mitigating oxidative stress and autophagy through the AMPK/Nrf2 pathway
Abstract
Background: Diabetic nephropathy (DN) is a severe microvascular complication of diabetes mellitus and a primary reason for end-stage renal disease (ESRD). Isorhapontigenin (ISO), a natural derivative of stilbene, has significant anti-inflammatory and antioxidant effects. Nevertheless, its impact on DN remains elusive.
Methods: Human vascular endothelial cells (HUVECs) and podocytes were damaged by high glucose (HG). Cell viability and apoptosis were testified by the cell counting kit-8 (CCK-8) assay and flow cytometry, respectively. The mRNA profiles of antioxidant factors HO-1, NQO1, and Prx1 were monitored by real-time quantitative polymerase chain reaction (RT-qPCR). Western blotting (WB) was implemented to verify the expression of apoptosis-related proteins (Bax, Bad, and Bcl-XL), antioxidant factors (HO-1, NQO1, and Prx1), autophagy-related proteins (Beclin-1, ATG5, p62), podocalyxin (podocin, nephrin, and synaptopodin) and the AMPK/Nrf2 pathway. The levels of oxidative stress-related markers MDA, SOD and CAT were assessed with the corresponding kits. Compound C (CC), an inhibitor of AMPK, was deployed to probe the effects of modulating the AMPK/Nrf2 pathway on ISO in oxidative stress and autophagy in HUVECs and podocytes. Streptozotocin (STZ) was injected intraperitoneally into mice to establish an animal model of diabetes mellitus and to clarify the impact of ISO on the renal parameters such as serum creatinine, urea nitrogen and urinary protein in diabetic mice.
Results: ISO notably facilitated cell proliferation, impeded apoptosis, elevated the expression of antioxidant-related factors, alleviated HG-induced oxidative stress and activated autophagy in HUVECs and podocytes. ISO activated the AMPK/Nrf2 pathway. Attenuating AMPK diminished the protective effect of ISO on HUVECs and podocytes, curbed cell proliferation, intensified apoptosis and oxidative stress, and dampened autophagy. In-vivo experiments also displayed that ISO reduced histopathological damage, lowered serum creatinine, urea nitrogen and urinary ACR levels, and eased kidney damage in DN mice.
Conclusion: ISO attenuates HG-induced oxidative stress and activates autophagy by motivating the AMPK/Nrf2 pathway, exerting a protective effect on HUVECs and podocytes and reducing renal injury in DN mice.
Keywords: Isorhapontigenin; Podocyte; The AMPK/Nrf2 pathway; Vascular endothelial cell.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
LCZ696 improves oxidative stress injury in human podocytes induced by increased glucose levels via Nrf2/HO-1 signaling pathway.Eur J Med Res. 2025 Jul 9;30(1):598. doi: 10.1186/s40001-025-02883-y. Eur J Med Res. 2025. PMID: 40635044 Free PMC article.
-
Dapagliflozin restores autophagy and attenuates apoptosis via the AMPK/mTOR pathway in diabetic nephropathy rats and high glucose-induced HK-2 cells.Int Urol Nephrol. 2025 Jan;57(1):249-261. doi: 10.1007/s11255-024-04172-9. Epub 2024 Jul 29. Int Urol Nephrol. 2025. PMID: 39075258
-
Gastrodin ameliorates diabetic nephropathy by activating the AMPK/Nrf2 pathway.J Mol Histol. 2024 Dec;55(6):1327-1339. doi: 10.1007/s10735-024-10273-7. Epub 2024 Nov 9. J Mol Histol. 2024. PMID: 39520653
-
Sestrin2 Signaling Pathway Regulates Podocyte Biology and Protects against Diabetic Nephropathy.J Diabetes Res. 2023 Feb 10;2023:8776878. doi: 10.1155/2023/8776878. eCollection 2023. J Diabetes Res. 2023. PMID: 36818747 Free PMC article. Review.
-
Activation of Nrf2/HO-1 signaling: An important molecular mechanism of herbal medicine in the treatment of atherosclerosis via the protection of vascular endothelial cells from oxidative stress.J Adv Res. 2021 Jul 6;34:43-63. doi: 10.1016/j.jare.2021.06.023. eCollection 2021 Dec. J Adv Res. 2021. PMID: 35024180 Free PMC article. Review.
Cited by
-
Targeting Autophagy: A Promising Therapeutic Strategy for Diabetes Mellitus and Diabetic Nephropathy.Diabetes Ther. 2024 Oct;15(10):2153-2182. doi: 10.1007/s13300-024-01641-3. Epub 2024 Aug 21. Diabetes Ther. 2024. PMID: 39167303 Free PMC article. Review.
-
Regulation of autophagy by natural polyphenols in the treatment of diabetic kidney disease: therapeutic potential and mechanism.Front Endocrinol (Lausanne). 2023 Aug 10;14:1142276. doi: 10.3389/fendo.2023.1142276. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37635982 Free PMC article. Review.
-
Poricoic acid a ameliorates high glucose-induced podocyte injury by regulating the AMPKα/FUNDC1 pathway.Mol Biol Rep. 2024 Sep 21;51(1):1003. doi: 10.1007/s11033-024-09921-8. Mol Biol Rep. 2024. PMID: 39305364
-
Diabetic neuropathy: cutting-edge research and future directions.Signal Transduct Target Ther. 2025 Apr 25;10(1):132. doi: 10.1038/s41392-025-02175-1. Signal Transduct Target Ther. 2025. PMID: 40274830 Free PMC article. Review.
-
Isorhapontigenin Inhibits Cell Growth, Angiogenesis, Migration, and Invasion of Non-Small-Cell Lung Cancer Cells Through NEDD9 Signaling.Int J Mol Sci. 2025 Apr 29;26(9):4207. doi: 10.3390/ijms26094207. Int J Mol Sci. 2025. PMID: 40362444 Free PMC article.
References
-
- Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Ishani A et al. US Renal Data System 2013 Annual Data Report. Am J Kidney Dis. 2014 Jan;63(1 Suppl):A7. https://doi.org/10.1053/j.ajkd.2013.11.001 . PMID: 24360288.
-
- Eid S, Sas KM, Abcouwer SF, Feldman EL, Gardner TW, Pennathur S, Fort PE. New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism. Diabetologia. 2019 Sep;62(9):1539–1549. https://doi.org/10.1007/s00125-019-4959-1 . Epub 2019 Jul 25. PMID: 31346658; PMCID: PMC6679814.
-
- American Diabetes Association. 11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020 Jan;43(Suppl 1):S135-S151. https://doi.org/10.2337/dc20-S011 . PMID: 31862754.
-
- Drummond KN, Kramer MS, Suissa S, Lévy-Marchal C, Dell'Aniello S, Sinaiko A, Mauer M; International Diabetic Nephropathy Study Group. Effects of duration and age at onset of type 1 diabetes on preclinical manifestations of nephropathy. Diabetes. 2003 Jul;52(7):1818–24. https://doi.org/10.2337/diabetes.52.7.1818 . PMID: 12829652.
-
- Reidy K, Kang HM, Hostetter T, Susztak K. Molecular mechanisms of diabetic kidney disease. J Clin Invest. 2014 Jun;124(6):2333–40. https://doi.org/10.1172/JCI72271 . Epub 2014 Jun 2. PMID: 24892707; PMCID: PMC4089448.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous